Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Pancreatic Adenocarcinoma Locally Advanced × Cryosurgery × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 4 Lung Neoplasms 2 Urinary Bladder Neoplasms 1 Unresectable Solid Tumors 1 Skin Neoplasms 1 Prostatic Neoplasms 1 Pancreatic Adenocarcinoma Locally Advanced 1 Neuroma 1 Neuralgia 1 Neoplasm Metastasis 1 Melanoma 1 Hypesthesia 1 High-Burden Metastatic Solid Tumors 1 Carcinoma, Transitional Cell 1 Agnosia 1 Adenocarcinoma of Lung 1 Adenocarcinoma 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07306286 2025-12-29

Cryoablation Combined With the Dual-Function Antibody PD-1/CTLA-4 for the Treatment of LAPC Following Failure of First-Line AG Therapy

Ruijin Hospital

Phase 2 Recruiting

Gastrointestinal

Pancreatic Adenocarcinoma Locally Advanced

Data powered by HemOnc (CC BY 4.0) Colophon ⚡